Clincosm LogoSign in Get a demo

Triple-Negative Breast Carcinoma

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 14, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
  • +5 more
Feb 11, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,

Recruiting
  • Stage I Breast Cancer AJCC v7
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +27 more
  • Aspiration of Breast
  • Biospecimen Collection
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

Collecting, Analyzing, and Storing Samples From Metastatic,

Terminated
  • Estrogen Receptor Negative
  • +4 more
  • Cytology Specimen Collection Procedure
  • +3 more
  • Seattle, Washington
  • +1 more
Sep 23, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

Breast Adenocarcinoma, Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (Atezolizumab,

Active, not recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Completed
Has Results
  • Anatomic Stage II Breast Cancer AJCC v8
  • +20 more
  • Mirvetuximab Soravtansine
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2020

Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in

Completed
  • Advanced Malignant Solid Neoplasm
  • +24 more
  • Oxidative Phosphorylation Inhibitor IACS-010759
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2020

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)

Completed
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 18, 2020

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

Unknown status
Has Results
  • Estrogen Receptor Negative
  • +9 more
  • Chicago, Illinois
  • +1 more
Jun 25, 2020

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Unknown status
  • Anatomic Stage I Breast Cancer AJCC v8
  • +21 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2020

Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,

Completed
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Akt Inhibitor GSK2141795
  • +2 more
  • Washington, District of Columbia
  • +7 more
Aug 27, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
Has Results
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018

Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker

Completed
  • Basal-Like Breast Carcinoma
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +6 more
Jun 28, 2018

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Estrogen Receptor Negative Trial in Bronx, Columbus (drug, other, procedure)

Completed
  • BRCA1 Gene Mutation
  • +11 more
  • Bronx, New York
  • +2 more
Apr 20, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Houston (Dinaciclib, Epirubicin Hydrochloride,

Completed
  • Estrogen Receptor Negative
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 29, 2018